QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors
Clinical trial NCT05108779 · UNKNOWN
Trial details
- NCT number
- NCT05108779
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-09
- Primary completion
- 2024-12-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.